General information

Announcements(1)

Program

Sessions

Search presentations

Timetable

Tue. Mar 10, 2026

Wed. Mar 11, 2026

Thu. Mar 12, 2026

web_header_en.png

web_icon_ja.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

企画

Profile management

Announcements

Bookmark

Download PDF for print

New Business Planning＆Development Center, Tsubakimoto Chain Co., Ltd.

Session 1: Artificial vascular grafts are used for the reconstruction of blood vessels in patients with congenital heart disease. Currently available vascular grafts exhibit poor biocompatibility, which causes material degradation and excessive intimal proliferation. In addition, a lack of growth potential leads to reoperation. By applying hydrostatic pressure to human cultured cells, we established a method to fabricate high-strength vascular grafts. In vivo studies using rodent models, human cultured cell-derived vascular grafts showed good biocompatibility and growth potential. I will provide an overview of that in this seminar.<br>Session 2: Tsubakimoto Chain deliver automation solutions that enable our customers to realize their vision in drug discovery, life sciences, and regenerative medicine, backed by our proven material handling technologies and over 20 years of industry experience.

【J】Fabrication of human cultured cell-derived vascular graft

The 103rd Annual Meeting of The Physiological Society of Japan

Presentation Information

[1LS06-02]New Business Planning＆Development Center, Tsubakimoto Chain Co., Ltd.

Comment